Similar companies
| Company | Stocktwits Subscribers | |
|---|---|---|
 |
AmgenAMGN |
15,009 0% |
 |
Gilead SciencesGILD |
77,591 0% |
 |
Catalyst PharmaceuticalsCPRX |
15,490 0% |
 |
Inovio PharmaceuticalsINO |
92,239 0% |
 |
Anavex Life SciencesAVXL |
23,913 0% |
Royalty Pharma Stocktwits Subscriber Count
Royalty Pharma (RPRX) has 7,285 subscribers on Stocktwits, roughly flat (+0.2%) over the past three months.
With 7,285 subscribers, Royalty Pharma has a smaller Stocktwits following than Amgen (15,009) and Gilead Sciences (77,591).
Unlike daily Stocktwits mentions, which spike around news and earnings, subscriber count reflects sustained, long-term interest from the retail investor community.
How RPRX’s Stocktwits Community Feeds the AI Score
Stocktwits subscriber count is a direct read on the size of the retail investor community tracking RPRX. It is not a stock price on its own, but sustained growth in subscribers can reflect building retail interest. AltIndex feeds Royalty Pharma’s Stocktwits community into the RPRX AI Score as one of 25+ alternative data signals, weighed against sentiment, Reddit activity, and fundamentals.
For daily discussion volume, see RPRX Stocktwits mentions. For other retail-community metrics, see Reddit subscribers and Reddit mentions.
Month over Month
| Sep 2026 | 7,295 | |
| Aug 2026 | 7,284 | |
| Jul 2026 | 7,273 | |
| Jun 2026 | 7,276 | |
| May 2026 | 7,279 | |
| Apr 2026 | 7,285 |
Royalty Pharma Stocktwits Subscribers: Frequently Asked Questions
Royalty Pharma (RPRX) has 7,285 subscribers (7K) on Stocktwits, based on AltIndex’s tracking of the stock’s Stocktwits page.
Royalty Pharma's Stocktwits subscriber base has been roughly flat (+0.2%) over the past three months. View the trend chart above for the full history.
Stocktwits subscriber count is a proxy for the size of the retail investor community tracking a stock. Unlike daily mentions, which spike around news, subscriber growth reflects sustained interest. No single data point predicts a stock on its own, which is why AltIndex combines RPRX’s Stocktwits community with sentiment, Reddit activity, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Royalty Pharma underperforms its industry peers when it comes to Stocktwits Subscribers, ranking in the 5th percentile.
StockTwits is a social media platform designed specifically for the investing community. It enables investors and traders to share market insights, strategies, and real-time news updates. Essentially, it's a specialized network for financial market discussions, often characterized by brief, tweet-like posts.
Sign up and get more insights on Royalty Pharma.
See Royalty Pharma’s complete stocktwits subscribers history
Sign up to unlock 1-year and all-time charts for RPRX, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
